BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3872053)

  • 1. Hemodynamic effects of intravenous bepridil in patients with normal left ventricular function.
    Alpert JS; Benotti JR; Brady PM; McCue JE; Weiner BH; Ockene IS
    Am J Cardiol; 1985 Mar; 55(7):20C-24C. PubMed ID: 3872053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on hemodynamics and left ventricular ejection fraction of intravenous bepridil for impaired left ventricular function secondary to coronary artery disease.
    Josephson MA; Mody T; Coyle K; Singh BN
    Am J Cardiol; 1987 Jul; 60(1):44-9. PubMed ID: 3496779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
    Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
    Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic and antiischemic properties of intravenous bepridil in coronary artery disease.
    Remme WJ; Kruyssen DA; Van Hoogenhuyze DC; Hofman B; Krauss XH; Storm CJ
    Am J Cardiol; 1989 Mar; 63(11):670-5. PubMed ID: 2784281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.
    Upward JW; Daly K; Campbell S; Bergman G; Jewitt DE
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1589-95. PubMed ID: 3873868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic effects of intravenous verapamil in patients on chronic propranolol therapy.
    Reddy PS; Uretsky BF; Steinfeld M
    Am Heart J; 1984 Jan; 107(1):97-101. PubMed ID: 6691247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
    Haerer VW; Stauch M
    Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction.
    Pfisterer M; Burkart F; Müller-Brand J; Kiowski W
    J Am Coll Cardiol; 1985 May; 5(5):1205-11. PubMed ID: 3989133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridil.
    Verdouw PD; Scheffer MG
    Arzneimittelforschung; 1984; 34(1):21-5. PubMed ID: 6608356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
    Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
    Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of intravenous encainide in patients with heart disease.
    Tucker CR; Winkle RA; Peters FA; Harrison DC
    Am Heart J; 1982 Aug; 104(2 Pt 1):209-15. PubMed ID: 6808816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized delivery systems for intravenous nitroglycerin. Are they necessary?
    Young JB; Pratt CM; Farmer JA; Luck JC; Fennell WH; Roberts R
    Am J Med; 1984 Jun; 76(6A):27-37. PubMed ID: 6430075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bepridil-induced modifications of cardiac performance in the anesthetized dog: comparison with nitroglycerin and propranolol.
    Labrid C; Piris P; Lamar JC; Beaughard M
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):293-308. PubMed ID: 6803695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol.
    Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD
    Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure.
    Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA
    Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.